Case Report: Precancer - biomed-spb.ru Congress 2018/PDF/DR...Therapeutic proposal: 5 –fu 5% cream...

23
Case Report: Precancer DR J.C. BOTERO INTEGRATIVE ONCOLOGIST BARCELONA SPAIN Case Report: Precancer DR J.C. BOTERO INTEGRATIVE ONCOLOGIST BARCELONA SPAIN

Transcript of Case Report: Precancer - biomed-spb.ru Congress 2018/PDF/DR...Therapeutic proposal: 5 –fu 5% cream...

Case Report: Precancer

DR J.C. BOTERO

INTEGRATIVE ONCOLOGIST

BARCELONA SPAIN

Case Report: Precancer

DR J.C. BOTERO

INTEGRATIVE ONCOLOGIST

BARCELONA SPAIN

1.Barret’s Esophag

2.Neoplasia Intra cervical

3.Polyposis colonic

4.Leucoplasia oral

5.Melanoma in situ

6.Hyperqueratosis actinic

PRECANCER CASE REPORT

1. Barret’s Esophag

A 54 old -year man, profession: Industrial Engineer,

working how teacher in secondary level.

Nervious personality with high level stress

Smoking, No alochol

Chronic peptic dissease

Tired and difficult to make sense of life

3

BARRET’s ESOPHAG healed with Viscum Helixor

2

0

0

9

2

0

1

7

2

0

1

0

2

0

1

12013

Thoracic pain +

dyspepsi

Omeprazol 80 mg/day

Barret’s Esophag

Barret’s E. with dysplasi I

Barret’s E. with dysplasi III

¿ Esophaguectomi?

February May

VISCUM HELIXOR M SE I, II, IV

August

2

0

1

5

EsophagNORMAL

Barret’s E.Dysplasia I

Esophag normal

STOP VISCUM

4

Thermic graph in Celsius

365 days. May/2013

36

35

37

7 am 7 pm

5

CIN III

A 43 Year-old woman with promiscuous habits sexuals.

Irregular gynecological controls

Extreme fatigue, No febril reactions when she had

recurrents episodis of purulent tonsilitis

Chronic insomnia, loss weight, BMI: 19

6

7

2. CIN III healed with Helixor M

2008

2010

2011

2012

2013

DIAGNO

SIS

CIN III

CIN IIICIN II

ASCUS

2018

NORMAL

HELIXOR M 30 MG 2/7

8

NORMAL

2

0

1

5

3. Polypos of the Colon

Patient man 58 years old

Familiar antecedents Neoplasia Colon

Executive, high stress level

2016 digestive symptomatology . HLA DQ2 +

9

Polyposis Colon. Colonoscopic evolution

2000

3 Poly

p

hiperplas

ic

2004

StartHelix

or

2006

2 Poly

AdenSerrat

2007

4 Pol

Hyperplasic

2008

NO

POLYP

2009

NOPOLYP

2010

2 polyp

AdentúbuloVellos

2011 Poly

pAdenTubular

2017 NO PoLyp

HELIXOR P 50 mg 2 X Week

10

4. Melanoma in situ

Clark I Level. Melanoma in situ. Arm

A 60 years-old man, without familiar history.

Profession: Farmer in Mediterranen Land

11

Melanoma In Situ

12

13

VISCUM Helixor P

50 mg perilesional x week

x 3 months

Helixor 30 mg

Subcutaneous,

simultaneouly

x 3 years

14

8 months after

Melanoma In Situ. Viscum perilesional

15

5. Hiperkeratosis actínica pre Carcinoma Baso-cell

A 79 years-old man

Scalp multiple lessions of pre Carcinoma Baso-cell,

long period evolution

in differents steps of development.

Therapeutic proposal: 5 – fu 5% cream

16

17

5 months after

188 months after

12 months after

Hiperkeratosis actínica pre cancer

TOPIC TREATMENT WITH HELIXOR

HELIXOR P 500 MG / 20 ml Olive Oil.

TOPIC 3 times every day

19

6. Squamos cell carcinoma skin treated with VAE

Cutaneous squamous cell carcinoma (CSCC)

A 78-year-old man, the patientrefused Surgical excision

Peri-lesional high –dose – week of VAE

After 10 months of treatment the CSCC had disappeared

The patient has been recurrence-free for 4 years

20

21

7 Week with

VAE

16 week

24 week

22

Timeline Cutaneous Squamous Carcinoma

Viscum Album per week < dosage Viscum album max dosage

23